One in two people will develop some form of cancer in their lifetimes. Despite decades of work, one-sixth of worldwide deaths are due to cancer. High-stakes research underpinned by strong alliances are making possible new therapies, bringing new hope.

In this podcast, Julie Little (Associate Director of Strategic Alliances) and Steve Wedge (Chief Scientific Officer) of Cancer Research UK discuss their organisation’s major role de-risking oncology research. CRUK has catalysed collaborations including biotech startups and big pharmaceutical companies alike. The newly formed Cancer Research Horizons will supercharge that mission.

BTD’s Nick Palmer leads the discussion. Learn more. Give it a listen.

#podcast #startups #biotech #research #oncology #pharmaceutical #alliances

A senior project, programme and integration professional, Louise Cooper joined the BTD team several years ago and has supported some of our largest and most complex engagements with clients such as Spectris and Glatfelter. In this podcast, Louise explores the differences between integration and more general transformation programmes, and what she finds challenging and fulfilling in her integration, separation and restructuring work.

www.btd.consulting
CLICK HERE to follow us on LinkedIn

All pharmaceutical companies look to leverage their capabilities to benefit those in the World’s poorest countries. Novartis aims to go beyond corporate philanthropy to create a more sustainable therapy-development model. By marshalling partnerships and its own people, Charlie Bailey leads Novartis teams pursuing development initiatives addressing better-known conditions like malaria, as well as more obscure ones like leishmaniasis. These initiatives can span a decade or more taking therapies through Phase I, II and III clinical trials, then ensuring the infrastructure and skills to offer them in the world’s most remote locations.

In this fascinating podcast, Charlie discusses the ideas behind Novartis’s access-focused product partnerships with BTD partner, Nick Palmer. Charlie explains how this new model offers a more sustainable path to addressing suffering in the Third World. Working with NGOs ranging from the Wellcome Trust and the Gates Foundation, to specialised ones like DNDi and MMV, Novartis is charting a course to bring First World therapies to the Third world, AND to push the boundaries of pharmaceutical innovation. He discusses specific examples and experiences to highlight this exciting approach.

CLICK HERE to follow us on LinkedIn
www.btd.consulting

John Palmer is a Senior Consultant who joined BTD in 2018, bringing his deep experience in business analysis and financial modelling to the team and our clients. John also leads our recruitment efforts and is pivotal in ensuring new team members – senior or junior – have the right skills, experience and values to join the BTD team. In this podcast, John shares his client experiences over the past few years and offers his view on what makes BTD, our team and our approach, different.

Barbara Vrdlovec joined BTD over ten years ago, and as our newest Director has seen almost every aspect of the business and our client work since then, supporting clients such as bwinParty, Glatfelter, and Innogy. She also leads our relationship with the Institute of Mergers, Acquisitions and Alliances (IMAA), providing training to groups worldwide. In this podcast, Barbara shares her view of how M&A and integration has changed over the past decade, what brought her to this field, and her hopes for the future of BTD.

Introducing our newest Partner and Head of our US practice, Nick Palmer. In this podcast, Nick discusses his 35 years in consulting and his approach to creating value for clients. Nick and Carlos discuss approaches and ideas that can help executives and aspiring consultants to be more effective. Having developed and led Strategy Training at Accenture, Nick shares actionable recommendations useful to all.

www.btd.consulting

Congratulations – you’re now responsible for integrating the new acquisition, and therefore delivering the benefits of the deal. You’ve been given an integration Manager and team to support you, but ultimately you’re on the hook. If we closely track the project plan and manage the work efficiently, everything will work out fine; after all, leading and managing are just two words meaning the same thing, right?
In this, the final in our Back to Basics podcast series, Diana Chiang and Nick Palmer join Carlos Keener to provide BTD’s thoughts and experience on why leading the deal and integration – and more importantly, doing so from the front – is central to any successful delivery of lasting value from M&A. The team also offers their own practical tips to help senior executives lead a business and its people through the complexity, ambiguity, and downright fear that often faces them beyond the deal.

CLICK HERE to follow us on LinkedIn
www.btd.consulting

For over half a century, computing power has been an integral part of business models. Whether simply managing back-office functions or actually central to the company’s business, business needs ‘IT.’

For the same half century the prevailing icon of the IT-business partnership has been a cartoon-like conflict between the two – ‘pocket-protector geeks versus polyester-suited charlatans.’ During post-merger integration (PMI) this conflict is only heightened as IT has become a critical enabler of post-deal value creation.

Some firms build positive partnerships by the thoughtful integration of the two. In this podcast, Jakub Kuleczko of E.ON, David Wright of Stratygen Consulting, and Carlos Keener of BTD Consulting discuss practical approaches to using IT as a lynchpin for successful integration and delivery of benefits beyond the deal.

CLICK HERE to follow us on LinkedIn
www.btd.consulting